Search Results - "Carlsson, G.U."

3640 POSTER Cost Identification of Nordic-FLIRI, Nordic- FLOX, XELIRI and XELOX in Palliative Colorectal Cancer in Sweden-a Clinical Practice Model Approach by Pettersson, K, Carlsson, G.U, Holmberg, C, Sporrong, K. Kälvemark

Get full text

Independent clinical validation of a gene expression profile to predict benefit of 5-FU in metastatic colorectal cancer by Buhl, I.K., Carlsson, G.U., Saksena, P., Gustavsson, B., Christensen, I.J., Edsjö, A., Hansen, A., Knudsen, S., Jensen, P.B., Wettergren, Y.

Get full text

644P - Independent clinical validation of a gene expression profile to predict benefit of 5-FU in metastatic colorectal cancer by Buhl, I.K., Carlsson, G.U., Saksena, P., Gustavsson, B., Christensen, I.J., Edsjö, A., Hansen, A., Knudsen, S., Jensen, P.B., Wettergren, Y.

“…No biomarkers predict efficacy of 5-FU for metastatic colorectal cancer (mCRC). A gene expression based drug response predictor (DRP) had been shown to predict…”
Get full text

ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer by Carlsson, G.U., Guren, T.K., Haux, J., Pfeiffer, P., Taflin, H., Mavroudis, D., Georgoulias, V., Papadimitriou, C., Kentepozidis, N., Boumpas, D., Skintemo, L., Ganlöv, K.M.E., Gustavsson, B.

Get full text